CRISPR-Cas9 Screen Reveals New Drug Combination for Treating Liver Cancer
Using a combinatorial CRISPR-Cas9 screening platform, researchers have demonstrated how this novel two-drug regime can be used in combination with sorafenib to curb tumour cell growth. Accounting for...